Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-02-05, Stock:ABBV, The news for the past five days is as follows:
2021-01-29: NEWS1: Will Recovery in AbbVie's (ABBV) Earnings Continue in Q4?.NEWS2: Pharma Stock Roundup: JNJ, NVS Q4 Earnings, MRK & LLY's Coronavirus Updates.
2021-02-01: NEWS1: Will Humira, Cancer Drugs Drive AbbVie (ABBV) Q4 Earnings?.
2021-02-02: NEWS1: Amgen Earnings Meet Expectations, but Its 2021 Outlook Isn’t Inspiring Investors.NEWS2: Billionaire David Siegel’s Top 10 Stock Picks.NEWS3: Earnings Outlook for AbbVie.NEWS4: 3 Top Dividend Stocks With Yields Over 4%.
2021-02-03: NEWS1: AbbVie Stock Tops Buy Zone On Earnings Beat, Strong 2021 Guidance.NEWS2: Here's Why Investors Liked AbbVie's Q4 Results.NEWS3: AbbVie Lands In Buy Zone On Earnings Beat, Strong 2021 Guidance.NEWS4: AbbVie Lands In Buy Zone On Earnings Beat, Strong 2021 Guidance.NEWS5: AbbVie’s 4Q Profit Tops Analysts’ Estimates; Shares Gain.NEWS6: AbbVie (ABBV) Q4 Earnings & Sales Top, 2021 Outlook Bright.NEWS7: Unusual Options Activity Insight: AbbVie.NEWS8: With Clock Ticking on Humira, AbbVie Plans for 2021 Growth.NEWS9: AbbVie (ABBV) Q4 Earnings and Revenues Surpass Estimates.NEWS10: AbbVie Stock: AbbVie Earnings Top Estimates, Guidance Strong.NEWS11: AbbVie: Q4 Earnings Insights.NEWS12: AbbVie stock rallies after profit and revenue beats, upbeat outlook.NEWS13: AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results.NEWS14: The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision.NEWS15: AbbVie Beats Earnings Expectations as Sales Surge.
2021-02-04: NEWS1: My Best Advice to New Value Investors.NEWS2: Why AbbVie (ABBV) is a Great Dividend Stock Right Now.NEWS3: Company News for Feb 4, 2021.NEWS4: Morning Bell With Jim Cramer: GameStop Misses Opportunity.NEWS5: With EPS Growth And More, AbbVie (NYSE:ABBV) Is Interesting.NEWS6: AbbVie (ABBV) Q4 2020 Earnings Call Transcript.

Answer: Rise